dennis mccain
  • Home
  • Investing
    • Dividend Kings
    • Div Aristocrats
    • Div Champions
    • Business Dev Cos
    • Monthly Dividends
  • Options
    • Weekly Options

Best Ideas This Week

These companies are estimated to have a very nice one year total return on investment.

Home

Best Ideas 28 January 2018

1/26/2018

0 Comments

 
Picture
Here's a couple of stock ideas I'm looking at for next week. These are companies I'll consider investing in with any funds that become available in my accounts. I believe each of these has a greater potential return than analysts currently expect. 

​As with all of my investments, I'll start with a small position and then add to that position over time through dividend reinvestment, the sale of stock options and direct purchases on the open market.
Picture
Overstock.com, Inc. operates as an online retailer in the United States. The company operates through two segments, Direct and Partner. It offers brand name, non-brand name, and closeout products, including furniture, home decor, bedding and bath, housewares, jewelry and watches, apparel and designer accessories, health and beauty products, electronics and computers, and sporting goods, among other products; and sells various books, magazines, CDs, DVDs, and video games. The company also provides handcraft, fresh produce and other food, and insurance products. Overstock.com, Inc. sells its products and services through its Internet Websites located at overstock.com, o.co, and o.biz, as well as through the United States based third party logistics providers to international customer. The company was formerly known as D2-Discounts Direct and changed its name to Overstock.com, Inc. in October 1999. Overstock.com, Inc. was founded in 1997 and is based in Midvale, Utah.
(Summary) (Company) (Chart)
28 January 2018
Price $74.45
1yr Target $110.00
Analysts 1
Dividend $0.00
Payout Ratio 0.00%

1yr Cap Gain 47.75%
Yield 0.00%
1yr Tot Return 47.75%

P/E ---
PEG ---
Beta 1.53
​
EPS (ttm) $-0.43
EPS next yr $-0.51
Forward P/E ---
EPS next 5yr 4.00%
1yr Price Support ---

Market Cap $1.71 Bil
Revenues $1.81 Bil
Earnings $-10.80 Mil
Profit Margin ---

Quick Ratio 0.80
Current Ratio 0.90
Debt/Equity 0.34


1yr RevGR 8.56%
3yr RevGR 11.20%
5yr RevGR 11.28%

1yr EarnGR 390.00%
3yr EarnGR -47.59%
5yr EarnGR ---

1yr DivGR ---
3yr DivGR ---
5yr DivGR ---

ROA -2.50%
ROE -6.40%


NovoCure Limited engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) for the treatment of solid tumors. The company markets its proprietary therapy, TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer. It is also involved in conducting clinical trials for the use of TTFields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, and mesothelioma. The company markets its products in the United States, Germany, Switzerland, Japan, and other countries. NovoCure Limited was founded in 2000 and is based in Saint Helier, the Channel Islands.
(Summary) (Company) (Chart)
28 January 2018
Price $23.65
1yr Target $27.00
Analysts 5
Dividend $0.00
Payout Ratio 0.00%

1yr Cap Gain 14.16%
Yield 0.00%
1yr Tot Return 14.16%

P/E ---
PEG ---
Beta ---
​
EPS (ttm) $-0.83
EPS next yr $0.11
Forward P/E 223.11
EPS next 5yr 60.00%
1yr Price Support $6.60

Market Cap $2.07 Bil
Revenues $153.60 Bil
Earnings $-72.90 Mil
Profit Margin ---

Quick Ratio 5.30
Current Ratio 5.90
Debt/Equity 0.83

​
1yr RevGR ---
3yr RevGR ---
5yr RevGR ---

1yr EarnGR ---
3yr EarnGR ---
5yr EarnGR ---

1yr DivGR ---
3yr DivGR ---
5yr DivGR ---

ROA -27.30%
ROE -57.70%

​
Corcept Therapeutics Incorporated, a pharmaceutical company, discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. It offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. The company is also developing Korlym in combination with eribulin, which is in Phase I/II clinical trial to treat patients with metastatic triple-negative breast cancer; Korlym in combination with drug Abraxane that is in Phase II clinical trial to treat patients with triple-negative breast cancer; and Korlym combined with the androgen deprivation agent enzalutamide, which is in Phase II clinical trial to treat patients with metastatic castration-resistant prostate cancer. In addition, it develops CORT125134 for the treatment of patients with Cushing's syndrome and solid-tumor cancers; and CLIA-validated assay to measure expression of the gene FKBP5, which is stimulated by cortisol activity at glucocorticoid receptor. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.
​(Summary) (Company) (Chart)
28 January 2018
Price $25.10
1yr Target $20.75
Analysts 4
Dividend $0.00
Payout Ratio 0.00%

1yr Cap Gain -17.34%
Yield 0.00%
1yr Tot Return -17.34%

P/E 87.46
PEG 1.23
Beta 1.69


EPS (ttm) $0.29
EPS next yr $0.88
Forward P/E 28.69
EPS next 5yr 71.00%
1yr Price Support $62.48

Market Cap $2.82 Bil
Revenues $129.70 Mil
Earnings $35.40 Mil
Profit Margin 27.29%

Quick Ratio 3.70
Current Ratio 3.90
Debt/Equity 0.00
​
1yr RevGR 61.71%
3yr RevGR 97.39%
5yr RevGR ---

1yr EarnGR ---
3yr EarnGR ---
5yr EarnGR ---

1yr DivGR ---
3yr DivGR ---
5yr DivGR ---

ROA 41.50%
ROE 58.20%
​
Momo Inc. operates as a mobile-based social networking platform in the People’s Republic of China. The company’s platform includes its Momo mobile application and various related features, functionalities, tools, and services that are provided to users, customers, and platform partners. It offers Momo mobile application that enables users to establish and expand their social relationships based on locations and interests; and Hani, a live video application. The company also offers games, which are designed with various themes, cultural characteristics, and features to appeal to various segments of the game player community; paid emoticons, and mobile marketing services; and live video, value-added, and other services. The company was formerly known as Momo Technology Company Limited and changed its name to Momo Inc. Momo Inc. was founded in 2011 and is headquartered in Beijing, the People’s Republic of China.
(Summary) (Company) (Chart)
28 January 2018
Price $30.30
1yr Target $39.06
Analysts 17
Dividend $0.00
Payout Ratio 0.00%

1yr Cap Gain 28.91%
Yield 0.00%
1yr Tot Return 28.91%

P/E 20.58
PEG 0.45
Beta ---
​
EPS (ttm) $1.47
EPS next yr $2.14
Forward P/E 14.15
EPS next 5yr 45.52%
1yr Price Support $97.41

Market Cap $5.77 Bil
Revenues $1.18 Bil
Earnings $304.80 Mil
Profit Margin 25.76%

Quick Ratio 5.00
Current Ratio 5.00
Debt/Equity 0.00
​
1yr RevGR ---
3yr RevGR ---
5yr RevGR ---

1yr EarnGR ---
3yr EarnGR ---
5yr EarnGR ---

1yr DivGR ---
3yr DivGR ---
5yr DivGR ---

ROA 32.40%
ROE 39.60%
​
0 Comments

Best Ideas 21 January 2018

1/21/2018

0 Comments

 
Picture
Unfortunately I have no Best Ideas for the upcoming week. Everything I'm looking at has simply moved so much higher recently that I would hesitate to buy shares at this level. My previous Best Ideas are still great companies with great products, but there shares are now expensive. I'll be reviewing those for possible investments if and when any of them pullback to more reasonable levels. I wish everyone the best and hopefully I can find more ideas this week. 
0 Comments

Best Ideas 14 January 2018

1/14/2018

0 Comments

 
Picture
Here's a couple of stock ideas I'm looking at for next week. These are companies I'll consider investing in with any funds that become available in my accounts. I believe each of these has a greater potential return than analysts currently expect. 

​As with all of my investments, I'll start with a small position and then add to that position over time through dividend reinvestment, the sale of stock options and direct purchases on the open market.
Picture
Digi International Inc. provides Internet of Things networking hardware products and solutions. It operates in two segments, Machine-to-Machine and Solutions. It offers cellular routers that provide connectivity for devices over a cellular data network; cellular gateway products that enable devices or groups of devices to be networked in locations where there is no existing network or where access to a network is prohibited; radio frequency products that utilize a range of wireless protocols for PC-to-device or device-to-device connectivity; and Connect, Rabbit, and ARM-based embedded systems on module and single board computers for medical, transportation, and industrial device manufacturers. It also provides console and serial servers, as well as universal serial bus (USB)-to-serial converters, USB over IP products, and multiport USB hubs. In addition, it offers turn-key networking product design, testing, and certification services for wireless technology platforms and applications; implementation planning, application development, on-site support, installation, and customer training services; and Digi Remote Manager, a centralized remote device management solution to meet service level commitments and stay compliant with payment card industry standards, as well as to monitor, diagnose, and fix remote devices. Further, it provides Digi Smart Solution, a system that enables restaurants, groceries, convenience stores, pharmacies, schools, hospitals, and industrial sites to monitor the temperature of food and other perishable goods, as well as to track the completion of operating tasks by employees. It sells its products through a network of distributors, systems integrators, and value added resellers for various businesses and institutions, as well as to original equipment manufacturers and others in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company was founded in 1985 and is headquartered in Minnetonka, Minnesota.
(Summary) (Company) (Chart)
14 January 2017
Price $10.25
1yr Target $14.00
Analysts 4
Dividend $0.00
Payout Ratio 0.00%

1yr Cap Gain 36.58%
Yield 0.00%
1yr Tot Return 36.58%

P/E 29.62
PEG 0.99
Beta 1.47


EPS (ttm) $0.35
EPS next yr $0.39
Forward P/E 26.08
EPS next 5yr 30.00%
1yr Price Support $11.70

Market Cap $271.93 Mil
Revenues $181.60 Mil
Earnings $9.40 Mil
Profit Margin 5.17%

Quick Ratio 8.00
Current Ratio 9.70
Debt/Equity 0.00


1yr RevGR -29.96%
3yr RevGR ---
5yr RevGR ---

1yr EarnGR ---
3yr EarnGR ---
5yr EarnGR ---

1yr DivGR ---
3yr DivGR ---
5yr DivGR ---

ROA 2.80%
ROE 3.00%


Hudson Technologies Inc. operates as a refrigerant services company in the United States and internationally. It sells reclaimed and virgin refrigerants, and industrial gases; provides refrigerant management services, such as reclamation of refrigerants and laboratory testing, as well as re-usable cylinder refurbishment and hydrostatic testing; and separates crossed refrigerants. The company also offers RefrigerantSide services, including system decontamination to remove moisture, oils, and other contaminants, as well as refrigerant recovery and reclamation services; predictive and diagnostic services that are intended to predict potential problems in air conditioning and refrigeration systems under the Chiller Chemistry, Fluid Chemistry, and Chill Smart names; and SmartEnergy OPS service, a Web-based real time continuous monitoring service for measuring, modifying, and enhamcing the efficiency of energy systems comprising air conditioning and refrigeration systems. In addition, it participates in the generation of carbon offset projects. The company serves commercial, industrial, and governmental customers, as well as refrigerant wholesalers, distributors, contractors, and refrigeration equipment manufacturers; and customers in petrochemical, pharmaceutical, industrial power, manufacturing, commercial facility and property management, and maritime industries. Hudson Technologies, Inc. was founded in 1991 and is headquartered in Pearl River, New York.
(Summary) (Company) (Chart)
14 January 2017
Price $6.37
1yr Target $9.17
Analysts 3
Dividend $0.00
Payout Ratio 0.00%

1yr Cap Gain 43.95%
Yield 0.00%
1yr Tot Return 43.95%

P/E 19.72
PEG 0.66
Beta 1.08
EPS (ttm) $0.32
EPS next yr $0.45
Forward P/E 14.06
EPS next 5yr 30.00%
1yr Price Support $13.50

Market Cap $266.90 Mil
Revenues $123.50 Mil
Earnings $14.40 Mil
Profit Margin 11.65%

Quick Ratio 4.90
Current Ratio 9.80
Debt/Equity 0.00
1yr RevGR 32.31%
3yr RevGR 21.38%
5yr RevGR 18.93%

1yr EarnGR 114.28%
3yr EarnGR ---
5yr EarnGR 49.62%

1yr DivGR ---
3yr DivGR ---
5yr DivGR ---

ROA 10.30%
ROE 11.90%
Diodes Incorporated designs, manufactures, and supplies application-specific standard products in the discrete, logic, and analog and mixed semiconductor markets primarily in Asia, North America, and Europe. It primarily focusses on low pin count semiconductor devices with one or more active or passive components. The company offers discrete semiconductor products, such as performance Schottky rectifiers and diodes; Zener diodes, including tight tolerance and low operating current type performance Zener diodes; standard, fast, super-fast, and ultra-fast recovery rectifiers; bridge rectifiers; switching diodes; small signal bipolar and pre-biased transistors; MOSFETs; thyristor surge protection devices; and transient voltage suppressors. It also provides analog products comprising power management devices consisting of AC-DC and DC-DC converters, USB power switches, and low dropout and linear voltage regulators; standard linear devices, such as operational amplifiers and comparators, current monitors, voltage references, and reset generators; LED lighting drivers; audio amplifiers; and sensor products, including Hall-effect sensors and motor drivers. In addition, the company offers standard logic products comprising low-voltage complementary metal??oxide??semiconductor (CMOS) and high-speed CMOS devices, as well as ultra-low power CMOS logic products and analog switches; multichip products, as well as co-packaged discrete, analog, and mixed-signal silicon in miniature packages silicon and silicon epitaxial wafers; and crystals and oscillators. It sells its products to the consumer electronics, computing, communications, industrial, and automotive markets through direct sales and marketing personnel, independent sales representatives, and distributors. Diodes Incorporated was founded in 1959 and is headquartered in Plano, Texas.
(Summary) (Company) (Chart)
14 January 2017
Price $29.92
1yr Target $34.67
Analysts 3
Dividend $0.00
Payout Ratio 0.00%

1yr Cap Gain 15.87%
Yield 0.00%
1yr Tot Return 15.87%

P/E 49.87
PEG 1.76
Beta 1.13
EPS (ttm) $0.60
EPS next yr $1.72
Forward P/E 17.42
EPS next 5yr 28.40%
1yr Price Support $48.84

Market Cap $1.47 Bil
Revenues $1.02 Bil
Earnings $30.10 Mil
Profit Margin 2.94%

Quick Ratio 2.20
Current Ratio 3.10
Debt/Equity 0.38
1yr RevGR 10.98%
3yr RevGR 4.04%
5yr RevGR 8.20%

1yr EarnGR -34.70%
3yr EarnGR -16.87%
5yr EarnGR -21.74%

1yr DivGR ---
3yr DivGR ---
5yr DivGR ---

ROA 1.90%
ROE 3.70%
0 Comments

Best Ideas 7 January 2018

1/7/2018

0 Comments

 
Picture
Here's a couple of stock ideas I'm looking at for next week. These are companies I'll consider investing in with any funds that become available in my accounts. I believe each of these has a greater potential return than analysts currently expect. 

​As with all of my investments, I'll start with a small position and then add to that position over time through dividend reinvestment, the sale of stock options and direct purchases on the open market.
Picture
Corcept Therapeutics Incorporated, a pharmaceutical company, discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. It offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. The company is also developing Korlym in combination with eribulin, which is in Phase I/II clinical trial to treat patients with metastatic triple-negative breast cancer; Korlym in combination with drug Abraxane that is in Phase II clinical trial to treat patients with triple-negative breast cancer; and Korlym combined with the androgen deprivation agent enzalutamide, which is in Phase II clinical trial to treat patients with metastatic castration-resistant prostate cancer. In addition, it develops CORT125134 for the treatment of patients with Cushing's syndrome and solid-tumor cancers; and CLIA-validated assay to measure expression of the gene FKBP5, which is stimulated by cortisol activity at glucocorticoid receptor. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.
​(Summary) (Company) (Chart)
7 January 2017
Price $18.73
1yr Target $20.75
Analysts 4
Dividend $0.00
Payout Ratio 0.00%

1yr Cap Gain %
Yield 0.00%
1yr Tot Return %

P/E 65.26
PEG 0.92
Beta 1.88


EPS (ttm) $0.29
EPS next yr $0.88
Forward P/E 21.41
EPS next 5yr 71.00%
1yr Price Support $

Market Cap $2.15 Bil
Revenues $129.70 Bil
Earnings $35.40 Mil
Profit Margin %

Quick Ratio 3.70
Current Ratio 3.90
Debt/Equity 0.00


1yr RevGR 61.71%
3yr RevGR 97.39%
5yr RevGR ---

1yr EarnGR ---
3yr EarnGR ---
5yr EarnGR ---

1yr DivGR ---
3yr DivGR ---
5yr DivGR ---

ROA 41.50%
ROE 58.20%


Momo Inc. operates as a mobile-based social networking platform in the People’s Republic of China. The company’s platform includes its Momo mobile application and various related features, functionalities, tools, and services that are provided to users, customers, and platform partners. It offers Momo mobile application that enables users to establish and expand their social relationships based on locations and interests; and Hani, a live video application. The company also offers games, which are designed with various themes, cultural characteristics, and features to appeal to various segments of the game player community; paid emoticons, and mobile marketing services; and live video, value-added, and other services. The company was formerly known as Momo Technology Company Limited and changed its name to Momo Inc. Momo Inc. was founded in 2011 and is headquartered in Beijing, the People’s Republic of China.
(Summary) (Company) (Chart)
7 January 2017
Price $27.83
1yr Target $40.46
Analysts 17
Dividend $0.00
Payout Ratio 0.00%

1yr Cap Gain %
Yield 0.00%
1yr Tot Return %

P/E 18.91
PEG 0.42
Beta ---
​
EPS (ttm) $1.47
EPS next yr $2.15
Forward P/E 12.95
EPS next 5yr 45.52%
1yr Price Support $

Market Cap $5.67 Bil
Revenues $1.18 Bil
Earnings $304.80 Mil
Profit Margin %

Quick Ratio 5.00
Current Ratio 5.00
Debt/Equity 0.00


1yr RevGR ---
3yr RevGR ---
5yr RevGR ---

1yr EarnGR ---
3yr EarnGR ---
5yr EarnGR ---

1yr DivGR ---
3yr DivGR ---
5yr DivGR ---

ROA 32.40%
ROE 39.60%
​
NovoCure Limited engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) for the treatment of solid tumors. The company markets its proprietary therapy, TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer. It is also involved in conducting clinical trials for the use of TTFields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, and mesothelioma. The company markets its products in the United States, Germany, Switzerland, Japan, and other countries. NovoCure Limited was founded in 2000 and is based in Saint Helier, the Channel Islands.
(Summary) (Company) (Chart)
7 January 2017
Price $20.80
1yr Target $26.00
Analysts 4
Dividend $0.00
Payout Ratio 0.00%

1yr Cap Gain %
Yield 0.00%
1yr Tot Return %

P/E ---
PEG ---
Beta ---
​
EPS (ttm) $-0.83
EPS next yr $-0.01
Forward P/E ---
EPS next 5yr 60.00%
1yr Price Support ---

Market Cap $1.89 Bil
Revenues $153.60 Bil
Earnings $-72.90 Mil
Profit Margin ---

Quick Ratio 5.30
Current Ratio 5.90
Debt/Equity 0.83
​
1yr RevGR ---
3yr RevGR ---
5yr RevGR ---

1yr EarnGR ---
3yr EarnGR ---
5yr EarnGR ---

1yr DivGR ---
3yr DivGR ---
5yr DivGR ---

ROA -27.30%
ROE -57.70%
​
0 Comments
    Picture
    Dennis McCain

    Author

    I am an Individual Investor with specific interest in long term growth and then enhancing my returns with income from dividends and derivatives. I don't recommend stocks to anyone (it's a good way to lose friends) and no one reading this should misinterpret my blog as a recommendation for any type of investment. I am writing this solely for myself and my kids.

    Picture
    Top 100 Blogs for Dividend Investors

    Archives

    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014

    DISCLAIMER
     I am not a licensed investment adviser, and I am not providing investment advise for you on this site. Please consult with an investment professional before you invest your money. Any opinion expressed here should not be treated as investment advice. I am not liable for any losses suffered by any party because of data or information published on this blog. Past performance is not a guarantee of future performance. Unless your investments are FDIC insured, they may decline in value.

    Categories

    All

    RSS Feed

Powered by Create your own unique website with customizable templates.